Given the heatmap showing a significant increase in its expression in the non-KC group, we hypothesize that the abnormality in CRY2 may impact circadian rhythmicity, leading to metabolic disorders, influencing the normal expression of proteins in corneal tissue, and thus undermining its morphological and structural integrity. This evidence concerns the gene CRY2 and Other metabolic disease.